Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

Recruiting now · Not applicable

Conditions studied: Skin Cancer

In brief

The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.

Key facts

Study ID

NCT07222995

Run by

H. Lee Moffitt Cancer Center and Research Institute

People needed

2900

Starts

2025-10-10

Expected to finish

2030-10-10

Last updated by the study team

2026-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
• Be 18 years of age or older.
• Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
• Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
• Be able to provide informed consent (written or electronic).
• Prefer English or Spanish for communication and study materials.

You may not qualify if…

• Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
• Are unwilling or unable to complete the baseline assessment or return the saliva kit.
• Decline to provide informed consent.
• Are under 18 years of age.

Where it is running

• Moffitt Cancer Center — Tampa, Florida, United States (enrolling)
• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.